Busy specialty practice with 5 physicians. Specializing in high blood pressure and kidney disease. Currently running a Procrit Clinic for approx. 100 patients with anemia in CKD.
Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East. For more than three decades, HMC has been dedicated to delivering the safest, most effective and compassionate care to all its patients. HMC manages twelve hospitals – nine specialist hospitals and three community hospitals – as well as the National Ambulance Service and home and residential care services. In January 2016, HMC achieved the significant distinction of becoming the first healthcare system across the globe to have all its hospitals accredited by Joint Commission International under the Academic Medical Center accreditation program. Additionally, the National Ambulance Service, Home Healthcare Service, Stroke Service and Palliative Care, have all received this prestigious accreditation since 2011. To meet the needs of a rapidly growing population, HMC has announced ambitious plans to expand capacity across its network through to 2030. HMC is leading the development of the region’s first academic health system – combining innovative research, top-class education and excellent clinical care – and is committed to building a legacy of healthcare expertise in Qatar. HMC collaborates with key partners who are experts in Qatar and beyond, including Weill Cornell Medical College-Qatar, the Institute for Healthcare Improvement and Partners Healthcare, Boston. HMC is also the first hospital system in the Middle East to achieve institutional accreditation from the Accreditation Council of Graduate Medical Education – International (ACGME-I), which demonstrates excellence in the way medical graduates are trained through residency, internship and fellowship programs. For more information about working at HMC, please visit www.hmc.org.qa/en/employees_careers/employees_careers.aspx
Security & Compliance Standards Overview
Hypertension & Nephrology, Inc. has 21.95% more incidents than the average of same-industry companies with at least one recorded incident.
No incidents recorded for Hamad Medical Corporation in 2025.
Hypertension & Nephrology, Inc. cyber incidents detection timeline including parent company and subsidiaries
Hamad Medical Corporation cyber incidents detection timeline including parent company and subsidiaries
Last 3 Security & Risk Events by Company
Hitachi Vantara Pentaho Data Integration and Analytics Community Dashboard Framework prior to versions 10.2.0.4, including 9.3.0.x and 8.3.x display the full server stack trace when encountering an error within the GetCdfResource servlet.
Pentaho Data Integration and Analytics Community Dashboard Editor plugin versions before 10.2.0.4, including 9.3.0.x and 8.3.x, deserialize untrusted JSON data without constraining the parser to approved classes and methods.
A security flaw has been discovered in CTCMS Content Management System up to 2.1.2. The impacted element is an unknown function in the library /ctcms/libs/Ct_Config.php of the component Backend System Configuration Module. The manipulation of the argument Cj_Add/Cj_Edit results in code injection. The attack can be executed remotely. The exploit has been released to the public and may be exploited.
A vulnerability was identified in CTCMS Content Management System up to 2.1.2. The affected element is the function Save of the file /ctcms/libs/Ct_App.php of the component Backend App Configuration Module. The manipulation of the argument CT_App_Paytype leads to code injection. Remote exploitation of the attack is possible. The exploit is publicly available and might be used.
Weblate is a web based localization tool. In versions prior to 5.15, it was possible to accept an invitation opened by a different user. Version 5.15. contains a patch. As a workaround, avoid leaving one's Weblate sessions with an invitation opened unattended.
